EyePoint, Inc. Operating Lease, Expense
EyePoint, Inc. (EYPT) reported Operating Lease, Expense of $356.00 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2023-11-03
- EyePoint, Inc. operating lease, expense for the quarter ending 2023-09-30 was $356.00K, a 35.36% increase year-over-year.
- EyePoint, Inc. operating lease, expense for the quarter ending 2023-06-30 was $356.00K, a 23.61% increase year-over-year.
- EyePoint, Inc. operating lease, expense for the quarter ending 2023-03-31 was $355.00K, a 55.02% increase year-over-year.
- EyePoint, Inc. operating lease, expense for the quarter ending 2022-12-31 was $419.00K, a 82.97% increase year-over-year.
- EyePoint, Inc. operating lease, expense for fiscal 2022 was $1.20M, a 35.59% increase from fiscal 2021.
- EyePoint, Inc. operating lease, expense for fiscal 2021 was $885.00K, a 3.87% increase from fiscal 2020.
- EyePoint, Inc. operating lease, expense for fiscal 2020 was $852.00K, a 0.00% change from fiscal 2019.
- EyePoint, Inc. operating lease, expense for fiscal 2019 was $852.00K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2023-09-30 | $356.00K 10-Q · filed 2023-11-03 | $712.00K derived: sum of 2 quarters · filed 2023-11-03 | $1.07M 10-Q · filed 2023-11-03 | $1.49M derived: sum of 4 quarters · filed 2023-11-03 |
| 2023-06-30 | $356.00K 10-Q · filed 2023-08-04 | $711.00K 10-Q · filed 2023-08-04 | $1.13M derived: sum of 3 quarters · filed 2023-08-04 | $1.39M derived: sum of 4 quarters · filed 2023-11-03 |
| 2023-03-31 | $355.00K 10-Q · filed 2023-05-04 | $774.00K derived: sum of 2 quarters · filed 2023-05-04 | $1.04M derived: sum of 3 quarters · filed 2023-11-03 | $1.32M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-12-31 | $419.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $682.00K derived: sum of 2 quarters · filed 2023-11-03 | $970.00K derived: sum of 3 quarters · filed 2023-11-03 | $1.20M 10-K · filed 2023-03-10 |
| 2022-09-30 | $263.00K 10-Q · filed 2023-11-03 | $551.00K derived: sum of 2 quarters · filed 2023-11-03 | $781.00K 10-Q · filed 2023-11-03 | $1.01M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $288.00K 10-Q · filed 2023-08-04 | $518.00K 10-Q · filed 2023-08-04 | $746.00K derived: sum of 3 quarters · filed 2023-08-04 | $975.00K derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $229.00K 10-Q · filed 2023-05-04 | $458.00K derived: sum of 2 quarters · filed 2023-05-04 | $687.00K derived: sum of 3 quarters · filed 2023-05-04 | $900.00K derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $229.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $458.00K derived: sum of 2 quarters · filed 2023-03-10 | $671.00K derived: sum of 3 quarters · filed 2023-03-10 | $885.00K 10-K · filed 2023-03-10 |
| 2021-09-30 | $229.00K 10-Q · filed 2022-11-04 | $442.00K derived: sum of 2 quarters · filed 2022-11-04 | $656.00K 10-Q · filed 2022-11-04 | $867.00K derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $213.00K 10-Q · filed 2022-08-05 | $427.00K 10-Q · filed 2022-08-05 | $638.00K derived: sum of 3 quarters · filed 2022-08-05 | $851.00K derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | $213.00K 10-Q · filed 2022-05-06 | $425.00K derived: sum of 2 quarters · filed 2022-05-06 | $638.00K derived: sum of 3 quarters · filed 2022-05-06 | $851.00K derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $212.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $425.00K derived: sum of 2 quarters · filed 2022-03-14 | $638.00K derived: sum of 3 quarters · filed 2022-03-14 | $852.00K 10-K · filed 2022-03-14 |
| 2020-09-30 | $213.00K 10-Q · filed 2021-11-05 | $426.00K derived: sum of 2 quarters · filed 2021-11-05 | $640.00K 10-Q · filed 2021-11-05 | $851.00K derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-06-30 | $213.00K 10-Q · filed 2021-08-06 | $427.00K 10-Q · filed 2021-08-06 | $638.00K derived: sum of 3 quarters · filed 2021-08-06 | $851.00K derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $213.00K 10-Q · filed 2021-05-05 | $425.00K derived: sum of 2 quarters · filed 2021-05-05 | $638.00K derived: sum of 3 quarters · filed 2021-05-05 | $851.00K derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $212.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $425.00K derived: sum of 2 quarters · filed 2021-03-12 | $638.00K derived: sum of 3 quarters · filed 2021-03-12 | $852.00K 10-K · filed 2021-03-12 |
| 2019-09-30 | $213.00K 10-Q · filed 2020-11-06 | $426.00K derived: sum of 2 quarters · filed 2020-11-06 | $640.00K 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $213.00K 10-Q · filed 2020-08-05 | $427.00K 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | $213.00K 10-Q · filed 2020-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |